🧪 MS Trial Expansion, AI for MS Diagnosis, Alzheimer’s Patent, Duchenne Breakthrough & More!
In this week’s Neuroscience Updates, we spotlight pivotal breakthroughs advancing neurology and neurodegenerative disease research:
Key updates include:
🧪 Tiziana expands Phase 2 trial of intranasal foralumab for secondary progressive MS
💊 BioNxt prepares human study of sublingual Cladribine thin-film for MS
🧬 Dyne wins EMA Orphan Drug Status for Duchenne therapy DYNE-251
🧠 Silo Pharma files patent for Alzheimer’s intranasal treatment SPC-14
🤖 Uppsala develops AI model with 90 percent accuracy for MS progression detection
📢 Stay Ahead in Neuroscience Research!
✅ Like, share, and subscribe for weekly updates on Neuroscience
#Neuroscience #MultipleSclerosis #AlzheimersResearch #DuchenneMuscularDystrophy #Neurodegeneration #NeuroTech #ClinicalResearch #BiotechInnovation #HealthcareNews #LucidQuest #NeurologyUpdates